BioCentury
ARTICLE | Clinical News

Evolutec preclinical data

March 5, 2007 8:00 AM UTC

In a model of asthma, inhaled rEV576 significantly reduced airway hyper-responsiveness. The complement 5 (C5) inhibitor also reduced the number of eosinophils in the bronchoalveolar lavage fluid, whi...